Evidence Updated on Myocarditis After mRNA COVID-19 Vaccination
The incidence of myocarditis appeared to be higher with the Moderna vaccine than with the Pfizer-BioNTech vaccine.
COVID19 Vaccine
Reformulated Booster Shots Ready by September, White House Says
The Biden administration is working on contracts for the reformulated booster doses.
Odds of Hospitalization Lower With Remote Monitoring in COVID-19
Researchers observed a shorter length of stay and less intensive care use with a remote patient monitoring program.
Third, Fourth COVID-19 Vaccine Doses Boost Humoral Response in Seniors
Third and fourth doses were tied to significantly increased anti-S IgG titers in older adults, but the optimal timing of additional doses was not known.
Less Than Half of Parents Surveyed Plan to Get COVID-19 Vaccine for Youngest Children
About 43% of parents surveyed said they would not get their young children vaccinated against COVID-19.
Third Dose of COVID-19 Vaccine Appears Least Effective for Lymphoma Patients
Vaccine effectiveness against breakthrough SARS-CoV-2 infections was 10.5% for patients with lymphoma.
Fourth COVID-19 Vaccine Dose Safe for Immunocompromised
Local and systemic reactions were reported less frequently after the fourth dose than after the third dose.
CDC Report Addresses Impact of COVID-19 on Antimicrobial Resistance
Increases in resistant infections from 2019 to 2020 were seen for carbapenem-resistant Acinetobacter and antifungal-resistant Candida auris.
Infant Hospitalization for COVID-19 Reduced With Maternal Vaccination
The effectiveness of maternal vaccination against COVID-19 hospitalization in infants was 80% during delta and 38% during omicron.
Higher Antibody Titers Observed With Moderna’s Bivalent Omicron Booster Candidate
A 50mcg booster dose of mRNA-1273.214 elicited significantly higher neutralizing antibody responses against omicron subvariants BA.4 and BA.5 in adults.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...